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Lactococcus lactis is a gram-positive bacterium that is widely used in the food industry and is therefore
desirable as a candidate for the production and secretion of recombinant proteins. Previously, we
generated a L. lactis strain that expressed and secreted the antimicrobial cell wall-lytic enzyme lyso-
staphin. To identify lactococcal gene products that affect the production of lysostaphin, we isolated and
characterized mutants generated by random transposon mutagenesis that had altered lysostaphin activity.
Out of 35,000 mutants screened, only one with no lysostaphin activity was identified, and it was found to
contain an insertion in the lysostaphin expression cassette. Ten mutants with higher lysostaphin activity
contained insertions in only four different genes, which encode an uncharacterized putative transmem-
brane protein (llmg_0609) (three mutants), an enzyme catalyzing the first step in peptidoglycan biosyn-
thesis (murA2) (five mutants), a putative regulator of peptidoglycan modification (trmA) (one mutant),
and an uncharacterized enzyme possibly involved in ubiquinone biosynthesis (llmg_2148) (one mutant).
These mutants were found to secrete larger amounts of lysostaphin than the control strain (MG1363[lss]),
and the greatest increase in secretion was 9.8- to 16.1-fold, for the llmg_0609 mutants. The lysostaphin-
oversecreting llmg_0609, murA2, and trmA mutants were also found to secrete larger amounts of another
cell wall-lytic enzyme (the Listeria monocytogenes bacteriophage endolysin Ply511) than the control strain,
indicating that the phenotype is not limited to lysostaphin.
Lactococcus lactis is a gram-positive bacterium widely used
in the dairy manufacturing industry. Due to its GRAS (gener-
ally regarded as safe) status for certain applications, it is often
regarded as a promising candidate host for the production of
recombinant proteins of therapeutic interest. One such protein
is lysostaphin, an endopeptidase that is naturally produced by
Staphylococcus simulans biovar staphylolyticus ATCC 1362
(34). Lysostaphin specifically cleaves the pentaglycine cross
bridges of Staphylococcus aureus peptidoglycan and is able to
cause cell wall breakdown and consequent cell death. Interest
in this antimicrobial enzyme has increased in recent years due
to the worsening problem of methicillin (meticillin)-resistant S.
aureus, and several studies have demonstrated its usefulness in
the treatment of infections (3, 4, 17, 27, 28). Recombinant
lysostaphin was first produced in Escherichia coli in 1987 (32),
and more recently, it has been expressed in L. lactis using the
nisin-controlled gene expression system (21, 22). Recent work
in our group has demonstrated the expression and secretion of
active lysostaphin in several lactic acid bacteria, including L.
lactis (39).
Levels of heterologous proteins secreted by L. lactis and
other lactic acid bacteria are generally low, and efforts have
been made to improve the secretion efficiency by modifying
secretion signal sequences (5, 31), inactivating proteases (2, 23,
29), or supplying heterologous secretion machinery (26). In-
sights into protein secretion in L. lactis were gained when
Nouaille et al. identified 13 genes that affect the secretion
efficiency of a staphylococcal nuclease reporter enzyme (NucT)
by using random mutagenesis (25). The inactivation of these
genes resulted in either increased or decreased levels of se-
creted NucT. One gene of particular interest was dltA, whose
product catalyzes the incorporation of D-alanine residues into
lipoteichoic acids. The inactivation of dltA reduced NucT se-
cretion efficiency due to modifications of the cell wall leading
to negatively charged lipoteichoic acid interacting with the
positively charged Nuc and physical entrapment of NucT in the
peptidoglycan network.
In this study, we have used random transposon mutagenesis
to identify genes that affect the extracellular activity of lyso-
staphin expressed by L. lactis. Four uncharacterized genes
whose inactivation caused increases in the amounts of lyso-
staphin secreted by L. lactis were identified in this study. One
gene encodes a predicted membrane-embedded protein; two
genes are likely to affect cell wall peptidoglycan structure; and
the fourth gene may be involved in ubiquinone biosynthesis.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and growth conditions. The strains, plas-
mids, and oligonucleotides used are listed in Table 1. Lactococcus lactis subsp.
cremoris MG1363 was grown using M17 (Oxoid, Basingstoke, United Kingdom)
supplemented with 0.5% glucose (GM17) or 1% glucose (2GM17) and was
incubated at 30°C or 37°C as indicated for the experiments described below.
Listeria monocytogenes ATCC 19112 and S. aureus ATCC 49476 were grown in
brain heart infusion medium (Oxoid) and incubated at 37°C. Escherichia coli
JM109 (Promega, Madison, WI) was used in cloning experiments and was grown
in either Luria-Bertani medium or brain heart infusion medium (both from
Oxoid). Antibiotics were used at the following concentrations: ampicillin, 100
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g/ml for E. coli; erythromycin, 300 g/ml for E. coli and 5 and 2 g/ml for
plasmid- and chromosome-encoded resistance in L. lactis, respectively.
Construction of the L. lactis MG1363[lss] strain used for random insertional
mutagenesis. We constructed an MG1363 strain carrying the lysostaphin expres-
sion cassette (lss) on the chromosome (Fig. 1). Previously, this cassette (contain-
ing the Sep promoter, PSep; the Sep secretion signal, ssSep; a six-histidine tag; and
the gene encoding the mature lysostaphin protein) has been used to produce and
secrete lysostaphin in MG1363 (39). The lss cassette was integrated into the same
region of the inactive histidine biosynthesis (his) operon as previously described
(25) (Fig. 1). The strategy used to produce the MG1363[lss] strain was as follows.
The lss cassette was isolated as an XbaI/XhoI fragment from pSep-6  His-Lss
(39) (Table 1). This fragment was ligated to two his operon fragments in the same
orientation (the upstream his fragment from pBS-his1 digested using SalI/XbaI
and the downstream his fragment from pGT-his2 digested using XhoI/EcoRI)
and PCR amplified using primers His1Sal5 and His2Eco3 (Table 1). The result-
ing 3.9-kb PCR fragment was first cloned into the pGEM-T Easy vector (Pro-
mega) for sequencing purposes before being cloned into pGhost9:ISS1. Both
plasmids were transformed into E. coli JM109 before the pG9-his1-lss-his2 (Lss
Emr) plasmid was transformed into wild-type MG1363. Stable integration of lss
was performed in two steps. First, strain MG1363 with plasmid pG9-his1-lss-his2
was grown at 37°C and selected on a GM17 agar plate with 2 g/ml erythromycin.
This initial temperature-sensitive integrant, MG1363[pG9-his1-lss-his2], was con-
firmed by PCR using primers lss-Pst and His2-DS (Table 1; Fig. 1) to ensure that
the lss cassette was inserted in the his operon. Primer His2-DS binds to the
chromosome 26 bp downstream of the cloned his2 fragment. It was also con-
firmed to have lysostaphin activity on GM17SaB agar plates. These are GM17
agar plates containing 100 l of autoclaved 100-fold-concentrated S. aureus
ATCC 49476 cells, which are buffered with 0.2 M potassium phosphate buffer
(pH 7.0) (39). The integrant was then made temperature stable by excision of
pGhost9:ISS1 at 30°C. This temperature-stable integrant, MG1363[lss] (Fig. 1),
was then selected for lysostaphin activity and erythromycin sensitivity.
Mutagenesis and screening conditions. Random insertional mutagenesis was
performed on MG1363[lss] with pGhost9:ISS1 as previously described (19).
Approximately 50 CFU was plated onto each GM17SaB or GM17SaU (un-
buffered GM17SaB) agar plate with 2 g/ml erythromycin and was incubated
at 37°C for 48 h. The mutants were screened for the absence of halos or for halos
significantly larger than that produced by the control strain, MG1363[lss]. The
average diameter of the halo of the control strain, MG1363[lss], was 3.4 mm.
Larger halos from selected mutants had diameters 0.8 mm to 2.8 mm greater
than that produced by the control strain.
Characterization of the pGhost9:ISS1 insertion sites and isolation of stable
ISS1 mutants. The sites where pGhost9:ISS1 integrated into the chromosome
were determined as previously described (19). The flanking chromosomal DNA
TABLE 1. Strains, plasmids, and oligonucleotides used in this study
Strain, plasmid, or oligonucleotide Details Source, reference, orpurpose
Strains
E. coli JM109 Cloning host Promega
L. lactis MG1363 Plasmid-free L. lactis subsp. cremoris 10
L. lactis MG1363lss MG1363 carrying the lss cassette on the chromosome This study
L. monocytogenes ATCC 19112 Human spinal fluid isolate ATCC
S. aureus ATCC 49476 Methicillin-resistant S. aureus 39
Plasmids
pBluescript II KS () Ampr; 3.0 kb Promega
pGEM-3Zf Ampr; 3.2 kb Promega
pGEM-T Easy Ampr; 3.0 kb Promega
pGhost9:ISS1 Emr ori (Ts); 4.6 kb; nonreplicative in L. lactis at 37°C 19
pSep-6  His-Lss Ampr; pGEM-3Zf containing the PSep–ssSep–six-histidine–lss expression
construct (5.3 kb)
39
pBS-his1 Ampr; pBS containing a fragment of the MG1363 his operon on the 5 end
of the lss cassette (4.2 kb)
This study
pGT-his2 Ampr; pGEM-T Easy containing a fragment of the MG1363 his operon on
the 3 end of the lss cassette (4.2 kb)
This study
pGT-his1-lss-his2 Ampr; pGEM-T Easy vector containing the lss cassette within the his
operon (6.9 kb)
This study
pG9-his1-lss-his2 Emr; pGhost9:ISS1 containing the lss cassette within the his operon (7.6 kb) This study
pSep511sec Emr; pGhost:ISS1 containing the PSep–ssSep–six-histidine–Ply511 expression
construct (5.5 kb)
39
Oligonucleotides
His1Sal5 CAGGTCGACCTTTGGGAGTCGCCTTTGGCT Amplification of his1
His1Xba3 TACTCTAGACTGAAACATCAGCCCAGTATA
His2Xho5 AGACTCGAGGGCGCAAGCGACTATATCCGG Amplification of his2
His2Eco3 TTCGAATTCTTCTTCGCGCTCCTTGCGGTG
lss-Pst AACAGCTGCAGGAGCTGCAACACATGAACATTC 39
His2-DS TGTGATTTGGTACGACGCAGAATTCTAAAGT Amplification of
integrated lss
ISS1-seq1 CACGATAGCTTAGATTGTAACG 19
ISS1-seq2 GAACCGAAGAAATGGAACGCTC 19
FIG. 1. Structure of strain MG1363 carrying the lss expression cas-
sette. The mature lysostaphin gene was fused to the Sep promoter
(PSep) and secretion signal (ssSep) (hatched box) with a six-histidine tag
(filled box) at the N terminus of the lysostaphin gene. The asterisk
indicates the lysostaphin stop codon. The lss expression cassette was
integrated by single-crossover recombination into the middle of the his
operon in MG1363. PCR primers lss-Pst and His2-DS (dashed arrows)
were used to confirm that the lss expression cassette was integrated.
The pGhost9:ISS1 plasmid was excised from the chromosome by grow-
ing the single-crossover integrant at 30°C without erythromycin and
selecting for clones with lysostaphin activity and erythromycin sensi-
tivity.
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was sequenced using primer ISS1-seq1 for the EcoRI chromosomal junction or
ISS1-seq2 for the HindIII junction (Table 1). The mutated genes were identified
by sequence comparison with the recently sequenced genome of MG1363 (42).
The number of pGhost9:ISS1 integrations into the chromosome was determined
by Southern hybridization of EcoRI-digested DNA using a digoxigenin-labeled
ISS1 fragment as a probe. For further experiments, we isolated stable ISS1
mutants that grew at 30°C without erythromycin as previously described (19).
These mutants were then retested for their lysostaphin activities by streaking a
loopful of overnight cultures onto GM17SaB agar and GM17SaU agar and
then incubating the cultures at 30°C (or 37°C where indicated) for 2 days.
Prediction of operon structures. To determine if genes containing ISS1 inser-
tions were cotranscribed with downstream genes, two operon prediction methods
were used (9, 30). The accuracy of the method of Price et al. (30), which has been
estimated based on the prediction of experimentally proven operons and from
microarray expression data, is82% for most genomes. We have identified likely
cotranscribed downstream genes that were predicted by at least one of these two
methods. The programs are available at http://www.microbesonline.org/operons/
and http://operondb.cbcb.umd.edu/cgi-bin/operondb/operons.cgi.
Prediction of subcellular locations of proteins. Protein sequences were entered
into three different online programs: SOSUI, a predictor of transmembrane regions
(http://bp.nuap.nagoya-u.ac.jp/sosui/) (14); TMpred, a predictor of transmembrane
regions and protein orientation (http://www.ch.embnet.org/software/TMPRED
_form.html) (15); and the PHD transmembrane helix predictor (http://npsa-pbil.ibcp
.fr/cgi-bin/npsa_automat.pl?page/NPSA/npsa_htm.html) (33).
Cell fractionation, protein extraction, and Western blot analysis. Cell-associ-
ated fractions were prepared by boiling the cells from late-exponential- or early-
stationary-phase cultures in 2 sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) loading buffer. Proteins in the supernatants were
concentrated using 5% trichloroacetic acid as described previously (37). Proteins
were separated using SDS-PAGE, transferred to nitrocellulose filters (GE
Healthcare), and blocked with 1% casein (Roche Applied Science, Mannheim,
Germany). The membrane was probed with either an anti-His5 monoclonal
antibody (Qiagen, Hilden, Germany) at a 1:1,000 dilution or an anti-His6 mono-
clonal antibody (Sigma-Aldrich, St. Louis, MO) at a 1:3,000 dilution, followed by
a horseradish peroxidase-conjugated rabbit anti-mouse antibody (Dako,
Glostrup, Denmark) at a 1:1,000 dilution. The bound antibodies were detected
using the Lumi-Light chemiluminescence kit (Roche Applied Science). To quan-
tify the amounts of proteins, different nonsaturated film exposures were scanned
(CanoScan800F; Canon), and the total amounts of proteins from the supernatant
and cell-associated fractions were estimated with GeneTools software (Syngene,
Frederick, MD). Statistical analysis was carried out using Student’s t test.
Ply511 expression and secretion in [lss] mutant strains. The L. monocytogenes
bacteriophage endolysin Ply511 was transformed into wild-type MG1363; the
control strain, MG1363[lss]; and the lom[lss], murA2[lss], and trmA[lss] mutant
strains. The Ply511 gene was introduced into these strains using the pGhost9:
ISS1 plasmid under the control of the Sep expression system (pSep511sec) (39).
The transformed strains were tested for Ply511 activity against L. monocytogenes
on GM17LmB agar plates (GM17 with 5 g/ml erythromycin and 300 l of an
autoclaved 100-fold concentrate of L. monocytogenes ATCC 19112 cells, buffered
with 0.2 M potassium phosphate buffer [pH 7.0]) (39). Ply511 was also detected
by Western blotting using an anti-His6 monoclonal antibody (Sigma-Aldrich) as
described above.
Lysozyme resistance analysis. The lysozyme resistance test was performed as
described previously (40). Briefly, solutions of chicken egg white lysozyme
(Sigma Aldrich) in GM17 were freshly prepared and diluted 10-fold into molten
GM17 agar at 45°C. Then 5 l of overnight cultures diluted 10-fold was spotted
onto GM17 agar with various concentrations of lysozyme. The plates were then
incubated at 30°C or 37°C as indicated.
Transmission electron microscopy. Bacterial cultures grown for 3, 6, or 20 h
were fixed in 0.4% glutaraldehyde (ProSciTech)–0.1 M cacodylate buffer (pH
7.3). After overnight fixation, the cells were pelleted and washed in 0.1 M
cacodylate buffer. Cells were postfixed in 1% osmium tetroxide and embedded in
Spurr epoxy resin. Ultrathin sections (thickness, 50 to 100 nm) were cut and
stained with uracyl acetate and lead citrate stains prior to examination and
photography using the JEOL 1200 EX transmission electron microscope.
RESULTS AND DISCUSSION
Isolation and identification of mutants with altered lyso-
staphin activities. The purpose of this study was to identify
host factors in MG1363 that affect the secretion efficiency of
the peptidoglycan hydrolase lysostaphin, which has specific
activity against S. aureus. We adapted a previously described
method whereby random mutagenesis (using the ISS1 element
in plasmid pGhost9:ISS1) was used to identify host factors in
the secretion of the staphylococcal nuclease reporter (NucT) in
MG1363 (25). We screened more than 35,000 clones for sig-
nificantly increased or decreased lysostaphin activity on
GM17SaB and GM17SaU agar plates containing 2 g/ml
erythromycin. On that basis, 124 mutants were selected, and
their lysostaphin activities were confirmed using this agar plate
method by comparison to the control strain (MG1363[lss]).
Ten of the 124 initial mutants were confirmed to have halo
sizes significantly greater than that of MG1363[lss], while 1
mutant was confirmed as having no halo. The locations of
inserted pGhost9:ISS1 were identified by comparison of the
flanking sequences with the MG1363 genome sequence (42)
(Table 2; Fig. 2). The mutant with no lysostaphin activity re-
sulted from an insertion of pGhost9:ISS1 in the lss expression
cassette. This was expected, because ISS1 insertion is a random
event (19). Three mutants had independent insertions in a
gene encoding an uncharacterized putative transmembrane
protein (llmg_0609); five mutants had independent insertions
in the murA2 gene; one mutant contained an insertion just
upstream of trmA; and one mutant contained an insertion in a
gene encoding an uncharacterized putative enzyme involved in
ubiquinone biosynthesis (llmg_2148).
Examination of the MG1363 genome showed that it is pos-
sible that the llmg_0609, murA2, and llmg_2148 genes could be
part of different operons. Downstream genes predicted to be
located in these operons by at least one of two computational
prediction programs (9, 30) are shown in Table 2. Transcript
analysis by Dupont et al. (7) has shown that, due to the pres-
ence of a promoter in the ISS1 element, ISS1 (and pGhost9:
ISS1) insertion does not lead to polar effects on downstream
genes. Such effects are observed, however, when the ISS1 se-
quence, which encodes a putative transposase, is orientated in
the same direction as the interrupted genes. In our study, ISS1
elements were orientated in the same direction as the inter-
rupted genes in two llmg_0609 mutants (2190 and 24185) and
two murA2 mutants (18662 and 31397). In these mutants, it
would be expected that the genes downstream would be tran-
scribed and that the phenotypes would not be due to polar
effects. In the llmg_2148 mutant, the ISS1 element is in the
opposite orientation to the interrupted gene and therefore may
affect the transcription of the downstream fmt gene (Table 2).
It should also be noted that the ISS1 element in mutant 16270
has inserted 34 bp upstream of the trmA gene and in the
opposite orientation and is therefore expected to prevent its
transcription.
Plasmid pGhost9:ISS1 was excised from all mutants to cre-
ate temperature-stable mutants for further investigation.
These temperature-stable mutants were streaked onto
GM17SaB agar (without erythromycin) to reconfirm the lyso-
staphin activity phenotype. Southern hybridization analysis
showed that for each temperature-stable mutant, ISS1 trans-
position occurred only at one site (data not shown). The
llmg_0609 and llmg_2148 mutants retained their increased lyso-
staphin activities at 30°C, while large zones of activity were
observed only at 37°C for the murA2 and trmA mutants. The
amount of lysostaphin secreted, the generation time, and the
final culture pH were measured for all mutants (Table 2).
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The increases in the lysostaphin activities of the 10 mutants
were determined to be due to increases in the secretion of
lysostaphin over that by the control strain, MG1363[lss], as
determined by Western blot analysis (Fig. 2; Table 2). The
levels were determined by direct comparison to the amount
secreted by MG1363[lss], which was assigned a value of 1.0
(Table 2). The average increases ( standard deviations) in the
lysostaphin levels in the cell extracts and supernatants of the
three llmg_0609 mutants were 3.0-fold (0.2-fold) and 12.0-
fold (3.6-fold), respectively; both levels were significantly
higher than those of the control strain (P 	 0.01). The average
increase ( standard deviation) in the lysostaphin level in the
supernatants of the five murA2 mutants grown at 37°C was
6.2-fold (0.7-fold), and the level was significantly higher than
that of the control strain (P 	 0.01).
Characterization of genes that affect lysostaphin secretion.
The llmg_0609 gene has been annotated in the MG1363 ge-
nome as encoding PabC (42) but is unlikely to function as a
4-amino-4-deoxychorismate lyase like the PabC proteins of E.
coli and Bacillus subtilis (11, 35). It has recently been proposed
that the open reading frame of the true pabC gene in MG1363
is contained within the llmg_1154 open reading frame as a
fusion to pabB (41). Therefore, we propose to rename
llmg_0609 as lom (lysostaphin-oversecreting mutant), in order
to avoid confusion. GenBank searches revealed that Lom has
significant similarity only to hypothetical proteins or proteins
with putative functions not yet experimentally tested. Protein
sequence analysis of Lom revealed that a single transmem-
brane helix was predicted to lie in the central region (amino
acids 177 to 195) (Fig. 2) and that the C-terminal region ex-
tends outside of the membrane.
MurA2 is a putative UDP-N-acetylglucosamine enopyruvyl
transferase that catalyzes the first step in the biosynthesis of
peptidoglycan (20). As with other low-GC gram-positive bac-
teria (6), MG1363 has two MurA enzymes (MurA1 and
MurA2) (42). MurA2 in MG1363 is more closely related to
enzymes in related species that are annotated as the primary
MurA enzyme. For example, MG1363 MurA2 is 61% and 40%
identical to the B. subtilis MurAA and MurAB proteins, re-
spectively. Similarly, MG1363 MurA2 is 70% and 44% identi-
cal to the Streptococcus pneumoniae MurA1 and MurA2 pro-
teins, respectively. Interestingly, MG1363 MurA2, B. subtilis
MurAA, and S. pneumoniae MurA1 are more similar to the
MurA in E. coli and other species with just one MurA than are
the MurA paralogs in the gram-positive species. The simplest
explanation of this is that MG1363 MurA2, B. subtilis MurAA,
and S. pneumoniae MurA1 are orthologs of E. coli MurA and
may represent the primary MurA. Du et al. (6) demonstrated
that MurA1 and MurA2 were both enzymatically functional
and could substitute for each other in S. pneumoniae. In con-
trast, MurAB could not substitute for MurAA in B. subtilis
(16). The lack of a growth defect in the MG1363 murA2 mu-
tants (Table 2) would suggest that the MG1363 murA1 paralog
is able to substitute functionally for murA2. The hypothesis
that the role of MurA2 is distinct from that of MurA1 is
supported by previous studies that identified MurA2 proteins
in the cytoplasm of wild-type Lactococcus lactis subsp. lactis
IL1403 (12) and, in particular, showed that MurA2 proteins
were upregulated in response to acid stress in two MG1363
mutants (1). Since the lysostaphin oversecretion phenotype
was observed primarily under heat stress conditions at 37°C, it
is possible that MurA1 is not fully functional at this higher
temperature and that this allowed lysostaphin to be readily
exported through a defective cell wall. However, both exami-
TABLE 2. Characteristics of mutants with lysostaphin activity greater than that of the wild type
Mutant Genea Homologousprotein Predicted function
b
Downstream gene
possibly affected by ISS1
insertion (predicted
function)c
Proportion of lysostaphind
in the following fraction: Generation
time (min) pH
e
Cell
associated Supernatant
MG1363lss 1.0 (1.0) 1.0 (1.0) 67 (91) 4.3
2190 llmg_0609 Llmg_0609 Unknown (membrane location
predicted)
greA (transcription
elongation factor)
3.1 9.8 59 4.3
11135 3.1 10.1 61 4.5
24185 2.8 16.1 56 4.4
18662 llmg_0517
(murA2)
MurA2 UDP-N-acetylglucosamine
enolpyruvyl transferase
llmg_0518 (unknown
function)
3.0 (0.8) 3.4 (6.2) 63 (75) 4.3
24198 0.7 (2.0) 1.3 (5.4) 62 (76) 4.3
28801 1.3 (ND)f 1.3 (7.2) 59 (79) 4.3
31394 ND (ND) 2.4 (6.0) 57 (63) 4.3
31397 ND (ND) 2.8 (6.4) 64 (72) 4.3
16270 llmg_0640 TrmA (Spx) Temperature resistance;
transcription regulation
None 1.9 (1.2) 4.3 (7.2) 77 (55) 4.3
2194 llmg_2148 UbiG 3-Demethylubiquinone-9 3-
methyltransferase
fmt (methionyl-tRNA
formyltransferase)
3.3 6.6 56 4.4
a Gene in which pGhost9:ISS1 integration occurred.
b As determined by the annotation of the MG1363 genome available on GenBank.
c Downstream genes that are likely located in an operon with the ISS1-containing gene were predicted by computational methods (9, 30).
d The amount of lysostaphin secreted was determined by Western blot analysis of the total amount of lysostaphin in the cell-associated or supernatant fraction in
comparison to that for MG1363lss, which is assigned the index value 1.0. Values in parentheses are measurements taken from cultures grown at 37°C.
e Measured from overnight cultures grown in 2GM17 at 30°C.
f ND, lysostaphin was not detected in the cell-associated fraction by Western blot analysis.
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nation of cell morphology using light microscopy and determi-
nation of the thickness of cell walls using transmission electron
microscopy failed to reveal any differences between the murA2
mutants and the MG1363[lss] control strain grown at 30°C or
37°C (data not shown). SDS-PAGE analysis of Coomassie-
stained proteins from supernatant fractions showed that the
murA2 mutants did not release greater amounts of intracellu-
lar proteins than the control strain (MG1363[lss]) (data not
shown), suggesting that the former are not leaky.
TrmA has homology to Spx, an oxidative stress regulator in
B. subtilis (24), and seven genes in the trmA family are encoded
by the MG1363 genome (42). The inactivation of this gene has
been reported to confer various stress-resistant phenotypes.
Various random mutagenesis studies have identified trmA mu-
tants as able to relieve temperature sensitivity in recA (8) and
clpP (13) mutant strains and to confer resistance to tellurite
and oxidative stress on the wild type (38). In addition, a trmA
mutant has increased resistance against the hydrolytic activity
of lysozyme over the wild-type strain (40), due to a modified
cell wall. Veiga et al. hypothesized that TrmA competes with
SpxB, one of its paralogs, for the binding of RpoA, the 

subunit of RNA polymerase (40). The inactivation of trmA may
allow SpxB to better bind RpoA, and this interaction activates
the expression of oatA, encoding the lactococcal peptidoglycan
O-acetylase, thus modifying the cell wall so that it becomes
lysozyme resistant. The reason for the increased lysostaphin
secretion levels of the trmA mutant is not clear, but as with the
murA2 mutant, they may be due to an altered cell wall struc-
ture.
Finally, one of the mutants selected from the screening had
an inactivation in the gene annotated as llmg_2148. The basis
for the increased lysostaphin secretion of this mutant remains
unclear. This gene is annotated as a putative enzyme, 3-dem-
ethylubiquinone-9 3-methyltransferase (UbiG) (42), which in
E. coli is involved in ubiquinone biosynthesis (36). However,
llmg_2148 has no homology to functionally characterized
UbiG enzymes in databases.
The lom, murA2, and trmA mutants oversecrete another hy-
drolytic enzyme, Ply511. To examine whether this increase in
lysostaphin secretion is specific to lysostaphin, we compared
the abilities of the wild-type MG1363, the control strain
(MG1363[lss]), and the lysostaphin-secreting mutant strains
(lom[lss], murA2[lss], and trmA[lss]) to express another heter-
ologous protein, Ply511. Ply511 is a peptidoglycan-hydrolytic
endolysin (N-acetylmuramoyl-L-alanine amidase) from an L.
monocytogenes bacteriophage (18). All the strains transformed
with the Ply511 expression cassette pSep511sec (Table 1) dem-
onstrated activity against both L. monocytogenes and S. aureus,
as evidenced by zones of clearing on agar plates containing
autoclaved cells. We compared the zones of activity of Ply511
on GM17LmB agar plates but observed no differences in the
activity zones between the control strain and the mutant strains
(data not shown). Western blot analysis, however, conclusively
demonstrated that the amounts of Ply511 secreted into the
FIG. 2. Identification of the chromosomal loci of the nine lysostaphin-oversecreting mutants. (A) Locations of the three mutants with mutations
in the llmg_0609 gene at nucleotide positions 818 (mutant 24185), 1354 (mutant 11135), and 1408 (mutant 2190) from the start of the gene. The
predicted single transmembrane helix is located from amino acids 177 to 195 (dotted box). (B) Representative Western blot of lysostaphin in
supernatant fractions from MG1363[lss] and mutant 11135[lss] grown at 30°C. (C) The five independent insertions in the murA2 gene are located
at nucleotide positions 116 (mutant 28801), 753 (mutant 24189), 766 (mutant 31397), 1050 (mutant 31394), and 1220 (mutant 18662). (D) Rep-
resentative Western blot of lysostaphin in supernatant fractions from MG1363[lss] and mutant 28801[lss] grown at 37°C. (E) The single mutation
in the trmA gene (mutant 16270) is located 34 bp upstream of the start of the gene. (F) Representative Western blot of lysostaphin in supernatant
fractions from MG1363[lss] and mutant 16270[lss] grown at 37°C. The variable quantities of supernatants loaded in the Western blots are given
in the tables above the blots (B, D, and F).
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cell-associated and supernatant fractions by the lom[lss][511],
murA2[lss][511], and trmA[lss][511] mutant strains were signif-
icantly greater than those for the control strain, MG1363
[lss][511] (Fig. 3). The lack of correlation between Western
blot analysis and clearing zone size for Ply511 may be because
the zone size for wild-type Lactococcus expressing Ply511
(MG1363[lss][511]) is already very large (compared to clearing
zones from lysostaphin activity) and therefore may have satu-
rated the assay, despite the fact that only very low levels of
enzyme were produced. The large clearing zones generated by
Ply511 could be due to its ability to diffuse through the bacte-
rial-cell-containing agar more efficiently than lysostaphin.
murA2 and trmA mutants were more resistant to lysozyme
hydrolysis. A recent study has shown that a mutation in trmA
results in lysozyme resistance in MG1363 (40). In this study, we
found that a trmA mutant that expresses lysostaphin (trmA[lss])
is also more resistant to lysozyme than the wild-type lyso-
staphin-expressing strain (MG1363[lss]) (Fig. 4). Interestingly,
we observed that MG1363[lss] was much more sensitive to
lysozyme than the non-lysostaphin-secreting wild-type strain,
MG1363 (Fig. 4B). This result suggests that lysostaphin may be
cleaving lactococcal peptidoglycan during its passage through
the cell wall, thereby heightening the sensitivity to lysozyme.
According to Veiga et al. (40), the resultant interactions within
a trmA mutant give rise to changes in the acetylation and
thickness of peptidoglycan, thereby making it more resistant to
lysozyme hydrolysis. Therefore, the trmA mutant may also be
more resistant to the nonspecific degradation caused during
the secretion of lysostaphin and, as a result, may be able to
tolerate higher levels of protein secretion. We also observed
that the murA2[lss] mutant strain was moderately more resis-
tant to lysozyme than the control strain (MG1363[lss]) and that
the lysozyme resistance of wild-type MG1363 was greater at
30°C than at 37°C (Fig. 4B and C). Therefore, protection from
cell wall-lytic enzymes (lysozyme and lysostaphin) is likely to be
attributable to modifications in the peptidoglycan structure
resulting from mutations in trmA and murA2; however, this has
yet to be confirmed.
In conclusion, we have identified four genes involved in the
secretion of lysostaphin in MG1363. These genes are different
from those previously identified in the NucT study (25), sug-
gesting that lactococcal host factors that affect the secretion of
heterologous proteins differ depending on the protein of in-
terest. While the mechanisms remain unknown, the inactiva-
tion of these four genes significantly increased the amount of
lysostaphin secreted without any detrimental effects to the host
cell and the growth rate. We also describe the construction of
novel MG1363 strains that are able to secrete two kinds of
peptidoglycan hydrolases, lysostaphin and Ply511. The results
of this study clearly provide new insights into lactococcal host
factors important for the secretion efficiency of heterologous
proteins, which may have applications in the food and phar-
maceutical industries.
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